Channel blocker treats asthma in the lab
Baylor College of Medicine News Today, in a recent edition of the Journal of Biological Chemistry, Beeton has shown that the synthetic analog, known as ShK-186, can inhibit the function of allergen-specific T lymphocytes from patients with asthma and in a rat model. T lymphocytes (a … |
View full post on asthma – Google News